Country: Israel
Language: English
Source: Ministry of Health
BUPIVACAINE HYDROCHLORIDE
PADAGIS ISRAEL AGENCIES LTD, ISRAEL
N01BB01
SOLUTION FOR INJECTION
BUPIVACAINE HYDROCHLORIDE 5 MG/ML
EPIDURAL, CAUDAL, PUDENTAL, SACRAL, INTERCOSTAL, PARACERVICAL
Required
RECIPHARM MONTS, FRANCE
BUPIVACAINE
BUPIVACAINE
Long acting local anaesthetic.
2015-08-31
דומע 1 ךותמ 2 ךיראת 2102/10/ 01 םש םושירה רפסמו תילגנאב רישכתה ) 046 89 23721 01 ( Marcaine 0.5% םושירה לעב םש Libra Ltd - Pharm - O - Tec !דבלב תורמחהה טורפל דעוימ הז ספוט תושקובמה תורמחהה ןולעב קרפ יחכונ טסקט שדח טסקט Retro- and peribulbar injections with local anaesthetics may involve some risk of persistent ocular muscle dysfunction. Retrobulbar and peribulbar injections with local anaesthetic agents may involve some risk of persistent ocular muscle dysfunction. There have been post-marketing reports of chondrolysis in patients who have received continuous intra-articular infusion of local anaesthetics postoperatively. The majority of the cases reported involved chondrolysis in the shoulder joint. It has not been possible to establish a clear causal link due to several contributory factors. There is also inconsistency in the scientific literature regarding the mechanism of action. Continuous intra-articular infusion is not an approved indication for Marcaine. Paediatric population The safety and efficacy of Marcaine in children aged < 1 year has not been established. Only limited data are available. Use of bupivacaine for intra-articular block in children aged 1 to 12 years has not been documented. Use of bupivacaine for major nerve block in children aged 1 to 12 years has not been documented. For epidural anaesthesia, children should be administered gradually increasing דומע 2 ךותמ 2 doses proportional to their age and weight, since thoracic epidural anaesthesia in particular can result in severe hypotonia and decreased respiratory function. UNDESIRABLE EFFECTS Paediatric population Side effects in children are similar to those in adults, but early signs of local anaesthetic toxicity in children may be difficult to detect in cases where the blockade is given under sedation or general anaesthesia. If circulatory depression occurs, give intravenous fluids, dobutamine and if necessary nora Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Marcaine 0.5% 2 QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml Marcaine contains 5 mg bupivacaine hydrochloride. Excipient with known effect: Sodium 3.1 mg/ml. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Solution for injection. 4 CLINICAL PARTICULARS 4.1 Therapeutic indications Long acting local anaesthetic. 4.2 Posology and method of administration Marcaine should only be used by physicians with experience of regional anaesthesia or under the supervision of such a physician. The lowest possible dose for adequate anaesthesia should be sought. It is important to observe particular caution in order to prevent inadvertent intravascular injections. Thorough aspiration before and during injection of the main dose is recommended. The main dose should be injected slowly at 25-50 mg/minute or in divided doses, while keeping continuous verbal contact with the patient and monitoring the heart rate. In epidural injection, the administration of high doses, a test dose of 3-5 ml Marcaine with adrenaline is recommended. An inadvertent intravascular injection can cause symptoms such as a transient increase in heart rate and an inadvertent intrathecal injection can cause signs of spinal block. The injection should be discontinued immediately if there are any toxic symptoms. The following doses are guidelines; the dosage should be adjusted according to the scope of the block and the patient's overall health status. In _infiltration anaesthesia_, administer Marcaine 5 mg/ml, 5-30 ml (25-150 mg bupivacaine hydrochloride). _ _ For _diagnostic and therapeutic blocks_: Marcaine 5 mg/ml, 0.5-20 ml (2.5-100 mg bupivacaine hydrochloride). For example, for trigeminal block 0.5-2.5 ml (2.5-12.5 mg) and for stellatum block 5-10 ml (25-50 mg) should be given. In _intercostal block_, administer Marcaine 5 mg/ml, 2-3 ml (10-15 mg bupivacaine hydrochloride) per nerve, up to a total of ten nerves. In _major blocks_ (such as epidural, sacral and brachial Read the complete document